Park West Asset Management’s Evolent Health EVH Stock Holding History

Park West Asset Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-327,617	Closed	-$10.1M	–	63
2022 Q2	$10.1M	Sell	327,617 -100,000	-23%	-$2.91M	0.57%	34
2022 Q1	$13.8M	Sell	427,617 -121,283	-22%	-$3.18M	0.48%	41
2021 Q4	$15.2M	Sell	548,900 -275,000	-33%	-$7.89M	0.3%	50
2021 Q3	$25.5M	Sell	823,900 -200,000	-20%	-$4.8M	0.61%	38
2021 Q2	$21.6M	Buy	1,023,900 +150,000	+17%	+$3M	0.62%	42
2021 Q1	$17.7M	Buy	+873,900	New	+$16.6M	0.53%	54
2020 Q4	–	Sell	-200,000	Closed	-$2.48M	–	130
2020 Q3	$2.48M	Buy	+200,000	New	+$2.35M	0.1%	86

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Park West Asset Management's EVH Position: Q3 2022 in Review

Park West Asset Management sold out of Evolent Health (EVH) in Q3 2022, closing a stake of 327,617 shares — an estimated $10.1M sold.

Park West Asset Management first reported a position in EVH in Q3 2020 and held it in 7 quarters. The position peaked at $25.5M in Q3 2021. 251 funds tracked by Wall St. Rank hold EVH as of Q3 2022.

Park West Asset Management reported no remaining Evolent Health position as of Q3 2022 after selling out during the quarter.
Park West Asset Management sold 327,617 Evolent Health shares in Q3 2022, an estimated $10.1M.
Park West Asset Management first reported a position in Evolent Health in Q3 2020 and held it in 7 quarters.
Park West Asset Management's Evolent Health position peaked at $25.5M in Q3 2021.
251 funds tracked by Wall St. Rank held Evolent Health as of Q3 2022.

Based on Park West Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.